Genotoxicity Testing Market Growth

Genotoxicity testing market growth is expected at a CAGR of 7% during the period 2023-2035

 

According to a recently published report by Roots Analysis, due to stringent regulatory guidelines issued to ensure safety of end-user and the growing pipeline of healthcare products, the demand for genotoxicity / mutagenicity testing is anticipated to grow considerable, thereby increasing the market at a steady pace.

Genotoxicity Testing Industry Overview

The global genotoxicity testing market is anticipated to grow at a CAGR of 7.0% from 2023-2035, reaching USD 2.7 billion by 2035.

Owing to the need for product safety, genotoxicity and mutagenicity testing emerge as crucial requirement, unraveling potential genetic hazards within pharmaceutical, chemicals and other products. This leads to the imperative need to identify substances causing genetic damage, with these testing procedures serving as the initial step, enabling the modification or elimination of harmful compounds during development. The advantages of these methods, such as early hazard identification and proactive risk mitigation lead to higher adoption in different product development including pharmaceutical, chemical, food. As industries seek precision and efficiency, the rising demand for genotoxicity and mutagenicity is increasing at a steady pace.

Browse 90+ figures and 200+ market data tables spread across 190+ pages and detailed Table of Content on “Genotoxicity Testing Market” Focus on Genotoxicity and Mutagenicity Testing Services: Distribution by Type of Assay, Assay / Test Offered, End User Industry and Geographical Regions: Industry Trends and Global Forecasts, 2023-2035” here: https://www.rootsanalysis.com/reports/genotoxicity-testing-services-market.html

Market Drivers

Driven by increasing regulatory requirements for safety assessments in pharmaceutical and chemical industries, the demand for genotoxicity and mutagenicity testing is increasing tremendously with time. Growing awareness of the potential health risks associated with genotoxic substances further fuels the demand. Advancements in testing methodologies, coupled with a rising emphasis on product safety evaluations, contribute to market expansion. Additionally, the continuous development of novel therapeutic compounds and chemicals amplifies the need for robust genotoxicity testing services, fostering market growth.

Market Restraints

High cost associated with comprehensive testing protocols, which may limit adoption, especially among smaller companies act as a barrier to the growth. Regulatory complexities and variations in testing requirements across regions pose challenges for standardization. Limited awareness and understanding of genotoxicity testing methodologies among some industry participants can impede market growth. Moreover, concerns related to the ethical use of animals in testing procedures contribute to regulatory scrutiny, impacting the testing services market.

Growth Factors

Increasing integration of in silico and in vitro testing methods, reducing reliance on traditional animal models has propelled the growth of genotoxicity and mutagenicity testing services all over the world. Technological advancements in automation and high-throughput screening enhance efficiency, and accelerate testing processes, thereby fostering market expansion. Rising global initiatives towards promoting drug safety and minimizing adverse effects contribute to the growing demand for comprehensive genotoxicity assessment services. Collaborations between regulatory bodies and industry stakeholders to establish standardized testing protocols also positively influence market growth. Moreover, the expanding scope of genotoxicity testing beyond pharmaceuticals to include chemicals, cosmetics and food products broadens market opportunities.

Genotoxicity Testing Market Segments

Based on the type of assay, the genotoxicity testing market is segmented into in vivo assays, in vitro assays and non-glp / screening assays.

• In vivo assays hold 59% share of the overall genotoxicity testing market in 2023.
• In vitro assays are anticipated to show a high growth potential during the forecast period of over 7% annually

Based on the Assay / Test Offered, the genotoxicity testing market is segmented into Comet Assay, Micronucleus Assay, Chromosomal Aberration Test, Gene Mutation Test and Others.

• Comet assays hold 47% share of the overall genotoxicity testing market share in 2023.
• Chromosomal Aberration Tests is anticipated to show the highest growth potential during the forecast period of over 7.2% annually.

Based on the End User Industry, the genotoxicity testing market is segmented into Chemical Industry, Healthcare Industry, Agriculture Industry, Cosmetic Industry and Other Industries.

• Chemical industry holds 63% share of the overall genotoxicity testing market in 2023.
• Cosmetic industry is anticipated to show the highest growth potential during the forecast period of over 6.7% annually.

Based on the Geographical Regions, the genotoxicity testing market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East and North Africa

• North America is anticipated to hold the maximum share (54%) of the global genotoxicity testing market in 2023.
• In Asia-Pacific, the genotoxicity testing market is anticipated to demonstrate lucrative growth during the forecast period.

Key Companies Profiled

The genotoxicity testing market report also includes detailed profiles of key players (listed below) that are offering testing services:

• Aurigene Pharmaceutical Serivces
• Charles River Laboratories
• GLR Laboratories
• Labcorp
• LSIM Safety Institute
• Sai Life Sciences
• Syngene

You Can Download Free Sample PDF Copy of This Report At: 
https://www.rootsanalysis.com/reports/genotoxicity-testing-services-market/request-sample.html

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

Contact Details

Gaurav Chaudhary
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com